AstraZeneca’s trial breast cancer drug fails to meet primary goals
AstraZeneca’s end-stage experimental trial to treat a certain type of breast cancer failed to meet its dual primary goals, according to a statement.
Drugs
Health
Pharma
Drugs
Health
Pharma
AstraZeneca, Daiichi’s breast cancer drug trials show rise in survival
HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials.
Drugs
Health
Pharma
Novartis AG to buy Mariana Oncology for $1 billion to build RLT assets
HQ Team May 2, 2024: Novartis AG will buy a US-based biotechnology company Mariana Oncology to expand its cancer portfolio for $1 billion..
Drugs
Health
Pharma
A new oral drug may stop triple-negative breast cancer in its tracks
HQ Team February 8, 2024: Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to.
Drugs
Health
Pharma
Cancer cases set to rise by 77% to 35 million in 2050: WHO global survey
More than 35 million people may have cancer in 2050 — an increase of 77% from 20 million new cases in 2022, according.
Drugs
Health
Pharma
J&J to purchase Ambrx Biopharma for $2 billion in all-cash deal
HQ Team January 8, 2023: Johnson & Johnson will buy Ambrx Biopharma, Inc., a company developing targeted chemotherapy treatments, for $2 billion in cash..
Drugs
Health
Pharma
Bristol Myer to pay China’s drugmaker Sichuan $8.4b to develop cancer drug
HQ Team December 12, 2023: Bristol Myers Squib will pay a total of $8.4 billion to SystImmune Inc., the US arm of Chinese.
Drugs
Health
Medical
Researchers uncover the role of dynein in breast cancer metastasis
HQ Team October 30, 2023: Researchers have unraveled a critical mechanism involving the dynein protein, shedding light on how it aids the spread.
Drugs
Health
Medical
Walkable environs cut risk of obesity-related cancers in women
HQ Team October 5, 2023: A new study by Columbia University Mailman School of Public Health and NYU Grossman School of Medicine says.
Drugs
Health
Pharma
Roche’s under-the-skin cancer injection gets Britain’s nod
HQ Team August 30, 2023: Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency. Tecentriq.